LA MONICA, Gabriele
LA MONICA, Gabriele
Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche
A Hybrid In Silico Approach for Identifying Dual VEGFR/RAS Inhibitors as Potential Anticancer and Anti-Angiogenic Agents
2025-10-18 Bono, A.; La Monica, G.; Alamia, F.; Tocco, D.; Lauria, A.; Martorana, A.
A novel in silico approach for identifying multi-target JAK/STAT inhibitors as anticancer agents
2024-11-23 Bono, Alessia; La Monica, Gabriele; Alamia, Federica; Lauria, Antonino; Martorana, Annamaria
Antiproliferative Activity Predictor: A New Reliable In Silico Tool for Drug Response Prediction against NCI60 Panel
2022-11-19 Martorana A.; La Monica G.; Bono A.; Mannino S.; Buscemi S.; Palumbo Piccionello A.; Gentile C.; Lauria A.; Peri D.
Antiproliferative Activity Predictor: un nuovo tool in silico per predire l’attività antiproliferativa nei confronti del pannello NCI60
2022-12-01 Gabriele La Monica, Annamaria Martorana, Alessia Bono, Salvatore Mannino, Silvestre Buscemi, Antonio Palumbo Piccionello, Carla Gentile, Daniele Peri, Antonino Lauria
Antiproliferative properties and g-quadruplex-binding of symmetrical naphtho[1,2-b:8,7-b’]dithiophene derivatives
2021-07-16 Lauria A.; La Monica G.; Terenzi A.; Mannino G.; Bonsignore R.; Bono A.; Almerico A.M.; Barone G.; Gentile C.; Martorana A.
Bioisosteric heterocyclic analogues of natural bioactive flavonoids by scaffold-hopping approaches: State-of-the-art and perspectives in medicinal chemistry
2024-07-15 La Monica, Gabriele; Bono, Alessia; Alamia, Federica; Lauria, Antonino; Martorana, Annamaria
Combinatorial chemistry-driven In silico design and computational evaluation of covalent peptidomimetic SARS-CoV-2 main protease inhibitors via structure-based virtual screening and multivariate analysis
2025-06-01 Bono, Alessia; La Monica, Gabriele; Alamia, Federica; Mingoia, Francesco; Martorana, Annamaria; Lauria, Antonino
Correlation between cell line chemosensitivity and protein expression pattern as new approach for the design of targeted anticancer small molecules
2022-11-15
COVALENT INHIBITION IN TRIPLE-NEGATIVE BREAST CANCER: DESIGN, SYNTHESIS AND BIOLOGICAL PROFILING OF ACRYLAMIDE-BASED QUINOLINES
2025-09-14 La Monica, G.; Occhipinti, C.; Alamia, F.; Bono, A.; Lauria, A.; Palumbo Piccionello, A.; D'Anneo, A.; Martorana, A.
Design and Synthesis of Novel Thieno[3,2-c]quinoline Compounds with Antiproliferative Activity on RET-Dependent Medullary Thyroid Cancer Cells
2023-09-26 La Monica, Gabriele; Pizzolanti, Giuseppe; Baiamonte, Concetta; Bono, Alessia; Alamia, Federica; Mingoia, Francesco; Lauria, Antonino; Martorana, Annamaria
Design, Synthesis, and In Silico Insights of new 4‐Piperazinylquinolines as Antiproliferative Agents against NCI Renal Cancer Cell Lines
2025-02-05 La Monica, Gabriele; Bono, Alessia; Alamia, Federica; Martorana, Annamaria; Lauria, Antonino
Development of an inhibitor of the mutagenic SOS response that suppresses the evolution of quinolone antibiotic resistance
2024-05-01 Bradbury J.D.; Hodgkinson T.; Thomas A.M.; Tanwar O.; La Monica G.; Rogga V.V.; Mackay L.J.; Taylor E.K.; Gilbert K.; Zhu Y.; Sefton A.Y.; Edwards A.M.; Gray-Hammerton C.J.; Smith G.R.; Roberts P.M.; Walsh T.R.; Lanyon-Hogg T.
Identification of biological targets through the correlation between cell line chemosensitivity and protein expression pattern
2021-10-01 Lauria, Antonino; La Monica, Gabriele; Gentile, Carla; Mannino, Giuseppe; Martorana, Annamaria; Peri, Daniele
In Silico Design of Dual Estrogen Receptor and Hsp90 Inhibitors for ER-Positive Breast Cancer Through a Mixed Ligand/Structure-Based Approach
2024-12-21 La Monica, G.; Alamia, F.; Bono, A.; Mingoia, F.; Martorana, A.; Lauria, A.
In Silico Design of New Dual Inhibitors of SARS-CoV-2 MPRO through Ligand- and Structure-Based Methods
2023-05-06 Bono, Alessia; Lauria, Antonino; La Monica, Gabriele; Alamia, Federica; Mingoia, Francesco; Martorana, Annamaria
In silico identification of small molecules as new cdc25 inhibitors through the correlation between chemosensitivity and protein expression pattern
2021-01-01 Lauria A.; Martorana A.; Monica G.L.; Mannino S.; Mannino G.; Peri D.; Gentile C.
In silico lead optimization and synthesis of a new series of thieno[3,2-c]quinoline with antiproliferative activity on RET-dependent medullary thyroid cancer cells
2023-12-11 Gabriele La Monica; Giuseppe Pizzolanti; Concetta Baiamonte; Alessia Bono; Federica Alamia; Giuseppe Siragusa; Francesco Mingoia; Antonino Lauria; Annamaria Martorana
In Silico Mixed Ligand/Structure-Based Design of New CDK-1/PARP-1 Dual Inhibitors as Anti-Breast Cancer Agents
2023-09-06 Bono, Alessia; La Monica, Gabriele; Alamia, Federica; Mingoia, Francesco; Gentile, Carla; Peri, Daniele; Lauria, Antonino; Martorana, Annamaria
Innovative In Silico Method for Discovering Multi-Target JAK/STAT Inhibitors as Potential Anticancer Therapies
2024-12-02 Bono Alessia; La Monica Gabriele; Alamia Federica; Lauria Antonino; Martorana Annamaria
Machine learning model for predicting molecular activity using Molecular Descriptors and ElectroShape Descriptors - FL051
2024-11-14 Alessia Bono; Aras Asad; Marco Albanese; Richard Ian Cooper; Antonino Lauria; Gabriele La Monica; Federica Alamia; Annamaria Martorana; Paul William Finn